Cronos Group (NASDAQ: CRON) released its fourth-quarter results on Feb. 26 for the period ending Dec. 31, 2020. The cannabis producer had some mixed results; it generated sales growth, but losses continued to mount. And down 21% over the past month, investors have been bearish on the stock -- it has performed worse than the Horizons Marijuana Life Sciences ETF, which has fallen by 14% during that time.

But before you decide whether to buy the pot stock on the dip, it's important to take a closer look at the earnings report to see just how well the business is doing. Here are the five of the most surprising numbers from Cronos' recent results. 

Image source: Getty Images

Continue reading

Source Fool.com